Immediate Impact

1 by Nobel laureates 55 standout
Sub-graph 1 of 22

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
2 intermediate papers

Works of Samanta Sarti being referenced

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
2018
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
2016

Author Peers

Author Last Decade Papers Cites
Samanta Sarti 473 201 187 201 46 770
Patrizia Serra 574 237 252 268 50 968
Guido Giordano 473 218 170 256 74 863
Lu Li 258 231 262 276 70 787
Blanca Cantos 386 183 199 454 47 934
Joline S.J. Lim 379 161 142 299 56 788
Annamaria Molino 509 343 104 187 38 859
Ciara C. O’Sullivan 561 285 246 287 71 959
Marco Johannes Battista 407 196 150 235 73 941
Ady Yosepovich 264 250 160 234 30 760
Helena Hwang 374 272 142 159 38 893

All Works

Loading papers...

Rankless by CCL
2026